17th week of 2014 patent applcation highlights part 46 |
Patent application number | Title | Published |
20140113787 | CONTAINER FORMING APPARATUS AND METHOD - An apparatus for forming a container from a blank is provided. The apparatus includes a blank feeder assembly, and a compression assembly including a mandrel assembly, an upper folding arm assembly including a plurality of folding arms moveable between a first position and a second position, a compression plate, and a rollover arm assembly. | 2014-04-24 |
20140113788 | PACKAGING PROCESS - A packaging process is provided. A package mother board having an upper surface, a lower surface, a device disposing area and a peripheral area surrounding the device disposing area is provided. Multiple semiconductor devices are disposed on the upper surface. The semiconductor devices are located in the device disposing area. A carrier having a center area and an edge area surrounding the center area is provided. An adhesive layer is formed between the peripheral area and the edge area. The center area of the carrier is disposed corresponding to the device disposing area of the package mother board. The edge area of the carrier is disposed corresponding to the peripheral area of the package mother board. The adhesive layer is in a state of semi-curing, and the package mother board is bonded to the carrier via the adhesive layer. A baking process is performed to completely cure the adhesive layer. | 2014-04-24 |
20140113789 | METHODS AND APPARATUS FOR FORMING AND SEALING A CONTAINER HAVING CENTERING TABS - A machine for forming and sealing a top of a container is provided. The machine includes a conveyor configured to transport the container through the machine, a forming section including at least one bullet arm configured to fold a trailing centering tab of the container, and a compression section downstream from the forming section and including a compression device configured to fold a leading centering tab of the container. | 2014-04-24 |
20140113790 | Heat Sealable Packaging Material with Improved Hot Tack - A method of forming a package includes depositing polyvinylidene chloride on a substrate, wherein the substrate comprises paper, drying the polyvinylidene chloride on the substrate to form a packaging material including less than 5 wt % water, applying water to the packaging material so that the packaging material includes at least about 8 wt % water, and bringing a first portion of the polyvinylidene chloride of the packaging material into contact with a second portion of the polyvinylidene chloride of the packaging material in the presence of heat to form a seal. The at least about 8 wt % water is operative for increasing a hot tack of the seal relative to the packaging material including less than 5 wt % water. | 2014-04-24 |
20140113791 | APPARATUS FOR TRIMMING PAPER ROLLS OR LOGS AND AN OPERATING METHOD FOR TREATING THE LOGS - Apparatus for trimming paper rolls or logs ( | 2014-04-24 |
20140113792 | Method And Apparatus For Forming An Adjustable Pant-Like Disposable Undergarment With Fully Severed Front Panel With Altered Area - A method and apparatus for producing a pre-fastened adjustable pant-like disposable absorbent undergarment including a fully severed front body panel is disclosed. The method includes the steps of providing a moving web and first creating an altered area on the moving web at an altering station to define a leading portion of the moving web and a trailing portion of the moving web connected at the altered area. The moving web then passes through a fastener attachment station to bridge the connected leading portion and trailing portion together with a fastener assembly that extends over the altered area. Finally, the moving web is then passed through a web breaking station to completely separate the leading portion and trailing portion of the moving web at the altered area, such that the leading portion and trailing portion remained bridged together by the fastener assembly. | 2014-04-24 |
20140113793 | Method and Apparatus for Advancing an Absorbent Article - A converting apparatus operates to transfer a folded absorbent article from a first carrier apparatus to a second carrier apparatus. The converting apparatus includes a transfer apparatus and a guide member located adjacent to the transfer apparatus, forming a gap there between. The transfer apparatus includes a frame that is rotatable about a first axis of rotation and a transfer member that is rotatable about a second axis of rotation. The transfer member defines a receiving surface and the guide member defines a guide surface. The guide surface converges toward the receiving surface. The frame advances the absorbent article in a machine direction through the gap. While advancing absorbent article advances through the gap, the transfer member rotates the absorbent article about the second axis of rotation. The guide member includes side seam tuckers that are adapted to tuck the side seams of the absorbent article. | 2014-04-24 |
20140113794 | DEVICE FOR MAKING A PAPER PAD PRODUCT - The present invention relates to a device ( | 2014-04-24 |
20140113795 | Sterilizable Photopolymer Serum Separator - Sterilizable separator tubes and methods of utilization of same are presented. Methods include providing a separator tube containing a separator substance that can be polymerized to a desired hardness following sterilization using radical generating radiation. The separator substance is formulated to have a density between that of the average densities of separable fractions derived from a sample fluid such as blood, and to be flowable. Upon centrifugation of a separator tube containing a fluid sample, the separator substance forms a barrier between the fractions. The barrier subsequently hardens to form a solid barrier when triggered by a suitable energy source. | 2014-04-24 |
20140113796 | CLOSABLE CENTRIFUGE CUP - A closable centrifuge cup, comprising a cup and a lid which can be placed on the cup edge, closes the cup opening and can be fastened under tension by means of at least one clamping element with its lid edge to the cup edge, characterized by at least one of the following properties:
| 2014-04-24 |
20140113797 | DEVICE AND METHOD FOR CUTTING BRITTLE MEMBER AND CUT-OUT BRITTLE MEMBER - A device for cutting a brittle member such as a glass is comprised of a laser oscillator configured to radiate a laser beam through a first space onto a first region on the brittle member; a cooling nozzle configured to expel a cooling medium onto a second region distinct from the first region on the brittle member; a baffle so disposed as to leave a gap between the member and the baffle and to have the first region not enclosed by the baffle, and so directed as to deflect a flow of a splash and a mist originating in the second region away from the first region; and a gas nozzle configured to expel a gas toward the gap. | 2014-04-24 |
20140113798 | FINING AGENTS FOR SILICATE GLASSES - A fining agent for reducing the concentration of seeds or bubbles in a silicate glass. The fining agent includes at least one inorganic compound, such as a hydrate or a hydroxide that acts as a source of water. In one embodiment, the fining agent further includes at least one multivalent metal oxide and, optionally, an oxidizer. A fusion formable and ion exchangeable silicate glass having a seed concentration of less than about 1 seed/cm | 2014-04-24 |
20140113799 | BORON AND FLUORINE-FREE GLASS FIBER COMPOSITES - This invention discloses a kind of boron and fluorine-free fiberglass composite with its characteristic that it has the following compounds under particular mix ratio: SiO | 2014-04-24 |
20140113800 | REFINED WHITE CERAMIC MATERIAL AND METHOD FOR PREPARING SAME - Disclosed is a refined white ceramic material, which belongs to the field of ceramic materials for component packaging, and comprises the following raw materials by weight in percentage: aluminum oxide 87-93, magnesium oxide 0.8-5, silicon dioxide 1-6, calcium oxide 0.6-4, titanium dioxide 0.01-0.5, and zirconium dioxide 0.5-3. The method for preparing same comprises: (1) washing aluminum oxide grinding balls and a ball-milling tank, and drying for later use; (2) weighing a solvent NP-10 of 0.5-4 by weight in percentage, and adding the solvent into the ball-milling tank; (3) weighing raw materials, adding the raw materials into the ball-milling tank, and performing ball milling for 72±0.5 h. By means of the refined white ceramic material of the present invention, the obtained ceramic grains have even sizes, small surface roughness, and high fracture resistance performance of ceramic body. | 2014-04-24 |
20140113801 | APPARATUS AND METHODS TO PRESERVE CATALYST ACTIVITY IN AN EPOXIDATION PROCESS - Apparatus and methods are provided for forming and processing multiphasic systems. In one embodiment, the invention provides a process for the manufacture of an epoxide, including reacting an olefinically unsaturated compound with an oxidant in the presence of a buffer component and a water-soluble manganese complex disposed in an aqueous phase having a first pH level in a first multiphasic system, adjusting the pH of the aqueous phase to a second pH level less than the first pH level, isolating at least a portion of the aqueous phase from the first multiphasic system, adjusting the pH of the at least a portion of the aqueous phase to a third pH level greater than the second pH level, and introducing the at least a portion of the aqueous phase into a second multiphasic system. | 2014-04-24 |
20140113802 | Surface Deposition-Type Honeycomb Catalyst For Flue Gas Denitrification and Preparation Method Thereof - This invention relates to the cleaning of flue gas released from various combustion processes, particularly a surface deposition NH | 2014-04-24 |
20140113803 | ROBUST PROMOTER CATALYST SYSTEM - A modified ion exchange resin catalyst having an attached dimethyl thiazolidine promoter is disclosed. Also disclosed is a process for catalyzing condensation reactions between phenols and ketones, wherein reactants are contacted with a modified ion exchange resin catalyst having an attached dimethyl thiazolidine promoter. Also disclosed is a process for catalyzing condensation reactions between phenols and ketones that does not utilize a bulk promoter. | 2014-04-24 |
20140113804 | ASYMMETRIC PHOSPHONIUM HALOALUMINATE IONIC LIQUID COMPOSITIONS - Quaternary phosphonium haloaluminate compounds according to Formula (I): | 2014-04-24 |
20140113805 | Method For Making Catalyst Compositions Of Alkali Metal Halide-Doped Bivalent Metal Fluorides And A Process For Making Fluorinated Olefins - There is provided methods for making a catalyst composition represented by the formula MX/M′F | 2014-04-24 |
20140113806 | BASIC CATALYST SUPPORT BODY HAVING A LOW SURFACE AREA - A catalyst support body containing an SiO | 2014-04-24 |
20140113807 | EXHAUST EMISSION CONTROL CATALYST - An exhaust emission control catalyst disclosed herein is equipped with a rhodium catalytic layer and a platinum catalytic layer, and is characterized in that a relationship between a mole average (X) of a Pauling's electronegativity that is calculated as to elements included in the rhodium catalytic layer except platinum group elements and oxygen and a mole average (Y) of a Pauling's electronegativity that is calculated as to elements included in the platinum catalytic layer except platinum group elements and oxygen is 1.30≦X≦1.45 and 1.47≦Y≦2.0. According to this exhaust emission control catalyst, an interlayer transfer of platinum and/or rhodium and the alloying of platinum and/or rhodium are suppressed during use of the catalyst, and high exhaust gas purification performance can be exerted. | 2014-04-24 |
20140113808 | NOx PURIFICATION CATALYST AND METHOD OF PRODUCING THE SAME - [Problem] The present invention provides a NO | 2014-04-24 |
20140113809 | Method of Modifying Nano-Porous Gas-Reforming Catalyst with High-Temperature Stability - A gas-reforming catalyst is modified to obtain stability in high temperature. The catalyst uses α-Al | 2014-04-24 |
20140113810 | METAL PARTICLES, EXHAUST GAS PURIFYING CATALYST COMPRISING METAL PARTICLES, AND METHODS FOR PRODUCING THEM - Provided are metal particles comprising an at least partial solid solution of rhodium and gold. Also provided is a method for producing metal particles comprising adding a boron-based reducing agent to a mixed solution containing a rhodium salt and a gold salt to produce the metal particles comprising an at least partial solid solution of rhodium and gold. Furthermore, provided are an exhaust gas purifying catalyst comprising the metal particles supported on a catalyst support and a method for producing the same. | 2014-04-24 |
20140113811 | NANOSTRUCTURED CARBON MATERIALS FOR ADSORPTION OF METHANE AND OTHER GASES - Provided are methods for storing gases on porous adsorbents, methods for optimizing the storage of gases on porous adsorbents, methods of making porous adsorbents, and methods of gas storage of optimized compositions, as in systems containing porous adsorbents and gas adsorbed on the surface of the porous adsorbent. The disclosed methods and systems feature a constant or increasing isosteric enthalpy of adsorption as a function of uptake of the gas onto the exposed surface of a porous adsorbent. Adsorbents with a porous geometry and surface dimensions suited to a particular adsorbate are exposed to the gas at elevated pressures in the specific regime where n/V (density) is larger than predicted by the ideal gas law by more than several percent. | 2014-04-24 |
20140113812 | REGENERATIVE PURIFICATION OF A PRETREATED BIOMASS STREAM - It is disclosed a process for removing at least a portion of the furfural and acetic acid in a first stream comprised of water, at least one compound selected from the group consisting of furfural and acetic acid, C5's and C6's. Such process comprises the steps of contacting the stream with an adsorption media which has been previously contacted with a second stream comprised of the same components and the adsorption media has been regenerated by exposing it to conditions, without being in contact with the second stream, such that at least 70% of the adsorbed furfural and acetic acid have each been desorbed and at least 60% of the C5's and C6's remain adsorbed on the media. | 2014-04-24 |
20140113813 | Irreversible Thermochromic Ink Compositions - An irreversible thermochromic ink composition can include thermochromic pigment capsules dispersed in a carrier. The irreversible thermochromic pigment capsules can include an inner core having a color changing dye, a color activator for activating the color changing dye, and a wax, an outer core surrounding the inner core and comprising a color destroying agent, and a shell surrounding the outer core. Alternatively, the irreversible thermochromic pigment capsules can include an inner core having a color destroying agent and a wax, an outer core surrounding the inner core and comprising a color changing dye and a color activator for activating the color changing dye, and a shell surrounding the outer core. Written marks made with the irreversible thermochromic inks can be rendered a different color or substantially colorless by application of a sufficient amount of heat to melt or substantially liquefy the wax in the irreversible thermochromic pigment capsules. | 2014-04-24 |
20140113814 | TEA EXTRACTS AND USES IN PROMOTING PLANT GROWTH - The present disclosure provides compositions that comprise extracts of oxidized tea (e.g., black tea) and methods for using such extracts in promoting plant growth, health or yield including seed germination, root development, vegetative growth, flowering, maturity, and plant yield. The present disclosure also provided portions of plants (e.g., seeds) treated with the extracts of oxidized tea. | 2014-04-24 |
20140113815 | AZOLE DERIVATIVE, METHOD FOR PRODUCING AZOLE DERIVATIVE, AND INTERMEDIATE COMPOUND - In order to provide a novel azole derivative, an azole derivative of the present invention is an azole derivative represented by a general formula (V′). (where R | 2014-04-24 |
20140113816 | PLANT GLUTAMINE SYNTHETASE INHIBITORS AND METHODS FOR THEIR IDENTIFICATION - Provided are methods for identification of plant glutamine synthetase inhibitors as well as the plant synthetase inhibitors identified. Further provided are methods of modulating glutamine synthetase activity in a plant, particularly weeds by applying to the plant or substrate for cultivating the plant a microorganism (e.g. | 2014-04-24 |
20140113817 | PEPTIDES WITH ANTIMICROBIAL ACTIVITY, DRUG COMPOSITIONS FOR THE TREATMENT AND PROPHYLAXIS OF ANIMALS, COMPOSITIONS FOR THE TREATMENT AND PROPHYLAXIS OF PLANTS, USES OF SAID PEPTIDES, AND USES OF PAENIBACILLUS ELGIL OUROFINENSIS EXTRACT - The present invention provides extracts of material fermented with | 2014-04-24 |
20140113818 | SOPHOROLACTONE COMPOSITIONS AND USES THEREOF - The present invention relates to a surfactant composition, consisting of 70 wt %-99.9 wt % sophorolactone, 0-1 wt % sophorolipid acid, less than 0.1% residual substrate, and remainder water. The invention further relates to products comprising this composition or hydrolysates thereof. The invention also relates to uses of these products and hydrolysates. | 2014-04-24 |
20140113819 | HIGH PRESSURE DISSOLVED OXYGEN GENERATION - Dissolved oxygen may be generated by adding a peroxide to a fluid stream and then catalytically decomposing the peroxide to generate oxygen. As the peroxide is catalytically decomposed, the oxygen may solubilize in a surrounding fluid so as to provide dissolved oxygen. In some examples, the amount of peroxide added to the fluid stream is controlled such that substantially all of the hydrogen peroxide added to the fluid stream catalytically decomposes and yet the dissolved oxygen concentration of the fluid stream does not exceed a dissolved oxygen saturation limit for the fluid stream. | 2014-04-24 |
20140113820 | MODIFICATION OF TREHALOSE-6-PHOSPHATE LEVELS IN PLANTS - Compounds which are trehalose-6-phosphate or trehalose-6-phosphonate precursors of formula (I) or agriculturally acceptable salts thereof are provided: (I) The compounds are useful in increasing starch production in plants. | 2014-04-24 |
20140113821 | POLYSACCHARIDE-BASED HYDROGEL POLYMER AND USES THEREOF - A method of preparing a hydrogel for delivery of an active agent. The method includes providing an aqueous solution that includes the active agent; dispersing or dissolving a gel-forming polymer in the aqueous solution to form a polymer solution; and cross-linking the polymer in the polymer solution to form the hydrogel which encapsulates the active agent. | 2014-04-24 |
20140113822 | COMBINATIONS OF DERIVATIZED SACCHARIDE SURFACTANTS AND ETHERAMINE OXIDE SURFACTANTS AS HERBICIDE ADJUVANTS - Efficacious herbicidal compositions comprising a derivatized saccharide surfactant and an amine oxide surfactant are described. The compositions are characterized as having low toxicity and are readily biodegradable. | 2014-04-24 |
20140113823 | FORMULATION COMPONENT - This invention relates to the use of aromatic esters as adjuvants in compositions, particularly for agrochemical use, as well to compositions comprising such an aromatic ester, in combination with at least one agrochemical and at least one surfactant. The invention further extends to methods of making and using such compositions. In particular the present invention relates to such compositions when formulated as, or comprised by, an emulsion concentrate (EC), an emulsion in water (EW), a suspension of particles in water (SC), a microcapsule formulation (CS), a suspension of particles with an emulsion (SE), a dispersion concentrate (DC) or an oil suspension (OD). | 2014-04-24 |
20140113824 | BICYCLIC (THIO)CARBONYLAMIDINES - Bicyclic (thio)carbonylamidines of the formula (I) | 2014-04-24 |
20140113825 | EMULSIFIABLE CONCENTRATE COMPRISING A DINITROANILINE COMPOUND - The present invention relates to an emulsifiable concentrate comprising an active ingredient being a dinitroaniline compound, preferably selected from the group consisting of pendimethalin, trifluralin, benfluralin, butralin, dinitramine, ethalfluralin, fluazinam, fluchloralin, flumetralin, oryzalin, prodiamine and mixtures thereof. The emulsifiable concentrate of the invention avoids especially crystallization at low temperature when the concentration of the active ingredient is high. | 2014-04-24 |
20140113826 | POLYSACCHARIDE ESTER MICROSPHERES AND METHODS AND ARTICLES RELATING THERETO - A method for producing a polysaccharide ester microsphere may include forming a polysaccharide ester product from a polysaccharide synthesis, wherein the polysaccharide ester product comprises a polysaccharide ester and a solvent; diluting the polysaccharide ester product, thereby yielding a polysaccharide ester dope; and forming a plurality of polysaccharide ester microspheres from the polysaccharide ester dope. Suitable polysaccharides may include, but are not limited to, starch, cellulose, hemicellulose, algenates, chitosan, and any combination thereof. Esters thereof may be organic esters (e.g., acetate and the like), inorganic esters (e.g., sulfonates and the like), or combinations thereof. Further, the solids conent of the polysaccharide ester dope, in some instances, may be greater than about 16 wt %. | 2014-04-24 |
20140113827 | AGRICULTURAL PESTICIDE COMPOSITIONS - An adjuvant composition for modifying the spray properties of an aqueous pesticide composition contains (a) at least one fatty deposition control agent, and (b)(ii) a liquid medium, one or more hydrotropes, and, optionally one or more surfactants, or (b)(ii) one or more surfactants, and adjuvant compositions for modifying the spray properties of an aqueous pesticide composition contains (c) at least one deposition control agent, and (d)(ii) a liquid medium, one or more hydrotropes, and, optionally one or more surfactants, or (d)(ii) one or more surfactants, and use thereof in agricultural applications. | 2014-04-24 |
20140113828 | ELECTRICAL, MECHANICAL, COMPUTING/ AND/OR OTHER DEVICES FORMED OF EXTREMELY LOW RESISTANCE MATERIALS - Electrical, mechanical, computing, and/or other devices that include components formed of extremely low resistance (ELR) materials, including, but not limited to, modified ELR materials, layered ELR materials, and new ELR materials, are described. | 2014-04-24 |
20140113829 | SYSTEMS AND METHODS OF SELECTING COMBINATORIAL COORDINATELY DYSREGULATED BIOMARKER SUBNETWORKS - Systems and methods of selecting combinatorial coordinately dysregulated biomarker subnetworks are provided. In one embodiment, a method comprises comparing the normalized gene expression data to a predetermined threshold to provide binary gene expression data associated with phenotype samples and control samples, analyzing subnetwork states of the binary gene expression data associated with phenotype samples and control samples to identify gene expression patterns that occur in phenotype samples and do not occur in control samples and identifying a subnetwork that provides gene expression patterns indicative of a sample being a phenotype sample. | 2014-04-24 |
20140113830 | Azoline Compound and Azole Compound Library and Method for Producing Same - An object of the present invention is to provide a method of efficiently constructing a library abundant in diversity and also usable for screening of a compound that binds to a target substance having protease activity. | 2014-04-24 |
20140113831 | ANTIBODY SCREENING METHODS - Provided are methods and compositions for the production of novel antibodies that bind specifically to a target anti gen. These methods and compositions are particularly useful for producing antibodies having the antigen binding specificity of a reference antibody but with improved properties (e.g., binding affinity, immunogenicity, and thermodynamic stability) relative to the reference antibody. | 2014-04-24 |
20140113832 | ENGINEERED THIOREDOXIN-LIKE FOLD PROTEINS - The invention features compositions based on thioredoxin-like fold protein domains described as engineered thioredoxin-like fold proteins (ETRXs). These proteins include one or more artificially diversified thioredoxin-like fold protein domains; each domain may be originated from the same or different thioredoxin-like fold protein domains. Features of the invention also include methods for identifying and preparing an enriched composition of target binding, loop-diversified ETRXs with additional sequence variations to improve affinity, stability, selectivity, or solubility. The invention also features compositions of ETRXs substituted with prosthetic groups, polymers, proteins, nucleic acids, carbohydrates, metals, natural or synthetic small molecules and toxins. | 2014-04-24 |
20140113833 | USE OF MULTIPLE RISK PREDICTORS FOR DIAGNOSIS OF CARDIOVASCULAR DISEASE - Methods and kits for characterizing the risk of developing cardiovascular disease are described. The methods include determining the levels of a plurality of risk predictors selected from the group consisting of B-type natriuretic peptide (BNP), myeloperoxidase (MPO), and high-sensitivity C-reactive protein (hsCRP) predictors in a biological sample from a subject. The levels of the plurality of risk predictors are then compared to corresponding control values to obtain a risk predictor differential for each risk predictor. The plurality of risk predictor differentials are then added to provide a cardiac biomarker score, and the cardiac biomarker score is compared to a reference biomarker score. A positive difference between the cardiac biomarker score and the reference biomarker score indicates the subject has an increased risk of developing cardiovascular disease compared to the risk of a reference population. The methods can be used for risk stratification. | 2014-04-24 |
20140113834 | HYBRIDOMA CLONES AND MONOCLONAL ANTIBODIES TO ING4 - The present invention is directed to a monoclonal antibody that recognizes human ING4 in its native form. The invention is also directed to a hybridoma cell line that produces the monoclonal antibody, and to methods of diagnosing cancer using the antibody. | 2014-04-24 |
20140113835 | CHEMICALLY-DEFINED ARRAYS FOR SCREENING CELL-SUBSTRATE INTERACTIONS - Patterned SAM arrays and methods of preparing patterned SAM arrays are disclosed. Advantageously, the methods used to prepare the patterned SAM arrays allow for controlling SAM spot-to-spot conditions such as ligand identity and ligand density, which allows for preparing a wide range of SAM spots in a single array format. Additionally, the patterned SAM arrays of the present disclosure support the culture of a range of cell types. The patterned SAM arrays offer the ability to rapidly screen substrate components for influencing cell attachment, spreading, proliferation, migration, and differentiation. | 2014-04-24 |
20140113836 | COMPOSITIONS, SYSTEMS AND METHODS FOR THE DIAGNOSIS, PREVENTION AND TREATMENT OF DISORDERS ASSOCIATED WITH AZETIDINE-2-CARBOXYLIC ACID - The present disclosure provides synthesized peptides containing azetidine-2-carboxylic acid (Aze), methods for detecting antibodies to peptides containing Aze, and methods for diagnosing conditions associated with misincorporation of Aze into host proteins. | 2014-04-24 |
20140113837 | SYSTEM AND METHOD FOR DETERMINING INDIVIDUALIZED MEDICAL INTERVENTION FOR A DISEASE STATE - A system and method for determining individualized medical intervention for a particular disease state, and especially for cancers, that includes the molecular profiling of a biological sample from the patient, determining whether any molecular findings including one or more genes, one or more gene expressed proteins, one or more molecular mechanisms, and/or combinations of such exhibit a change in expression compared to a reference, and identifying a non-specific disease therapy or agent capable of interacting with the genes, gene expressed proteins, molecular mechanisms, or combinations of such molecular findings that exhibited a change in expression. | 2014-04-24 |
20140113838 | Microfluidic Assay Apparatus and Methods of Use - Methods and microfluidic apparatus are disclosed for drug prediction. A microfluidic apparatus has (a) a plate, (b) a plurality of wells defined in the plate, (c) a plurality of closed microchannels defined in the plate, and (d) a sample platform defining a plurality of open microchannels, where the plurality of closed microchannels are each in communication with one of the plurality of wells and one of the plurality of open microchannels of the sample platform. | 2014-04-24 |
20140113839 | Methods of Making Oligonucleotide Probes - The present invention relates to methods of making linear nucleic acid probes using rolling circle amplification methods. | 2014-04-24 |
20140113840 | ANALYTE DETECTION SYSTEM WITH CLEANING PHASE AND RENEWABLE LIQUID SENSING MATERIAL AND METHODS THEREFORE - Methods and systems for detecting analytes using a sensor element having a cleaning cycle and renewable liquid material with an affinity for the analytes are described. An analyte detection system may include a controller in communication with a sensor element and a liquid dispensing assembly. The liquid dispensing assembly, such as an inkjet dispensing device, may deposit the liquid material on or adjacent to the sensor element. The controller may be operative to monitor at least one property associated with the liquid material deposited on the sensor element. In addition, the controller may be configured to generate at least one control signal based on the at least one property. The liquid dispensing assembly may be configured to deposit the at least one liquid material on the sensor element based on the at least one control signal. | 2014-04-24 |
20140113841 | BUBBLE-ENHANCED PROPPANT FOR WELL FRACTURING - Stable, gas-filled bubbles on the surface of proppant particles are formed by placing proppant in selected organic solvent having a much greater solubility of a selected gas compared to water, pressurizing the solvent with the selected gas, e.g., nitrogen, at pressures equal of greater than the operating pressure for a set time period to achieve saturation, and then replacing the solvent with water before reducing the pressure back to operating pressure level to create a local supersaturation near the solvent-solid interface, which will result in gas-filled bubble formation on the surface of proppant particles. The pressurized mixture of bubble surrounded proppant particles and water can then be combined with a respective fracturing fluid, e.g., slick water or carbon dioxide and/or nitrogen foam or an emulsion, which can be used in oil or gas producing wells to improve efficiency of hydraulic fracturing thereof. | 2014-04-24 |
20140113842 | BETAINE SURFACTANTS AND PREPARATION METHODS AND USES THEREOF - Betaine surfactants of formula (I) and preparation methods and uses thereof are provided. The surfactant can decrease the interfacial surface tension of crude oil till 10 | 2014-04-24 |
20140113843 | Wellbore Servicing Compositions and Methods of Making and Using Same - A method of servicing a wellbore in a subterranean formation comprising placing a composition comprising an acid and/or an acid precursor, a surfactant, and an aqueous base fluid into contact with oil-wet solids in the wellbore; wherein the acid and/or acid precursor is selected from the group consisting of acetic acid; lactic acid; glycolic acid; oxalic acid; propionic acid; butyric acid; monochloroacetic acid; dichloroacetic acid; trichloroacetic acid; hydrochloric acid; nitric acid; sulphuric acid; sulphonic acid; sulphinic acid; phosphoric acid; phosphorous acid; phosphonic acid; phosphinic acid; sulphamic acid; aliphatic polyesters; glucono-delta-lactone; glucoheptonic lactone; poly(ε-caprolactones); poly(hydroxybutyrates); poly(anhydrides); aliphatic polycarbonates; poly(amino acids); polyphosphazenes; poly(ortho esters); or combinations thereof. | 2014-04-24 |
20140113844 | FUNCTIONALIZED POLYMERS AND OLIGOMERS AS CORROSION INHIBITORS AND ANTIWEAR ADDITIVES - Provided are lubricant compositions and hydrocarbon fluids including one or more lubricant base stocks and an effective amount of one more zero SAP antiwear additives and/or corrosion inhibitor additives, wherein the one more antiwear and/or corrosion inhibitor additives include one or more functionalized polyolefins having one or more pyridazine moieties. Such compositions exhibit improved anti-wear, friction reduction and anti-corrosion properties. | 2014-04-24 |
20140113845 | LUBRICATING OIL COMPOSITION - A lubricating oil composition has excellent oxidation stability, suitable as a lubricating oil for internal combustion engines and automatic transmissions. The lubricating oil composition includes a lubricating base oil and one or more types of phosphorus compound represented by formula (1) as Component (A), the element ratio of sulfur derived from the compound of formula (1) to phosphorus in the oil (S/P molar ratio) being from 0.05 to 0.8 and the amount of phosphorus derived from Component (A) in the oil being from 0.01 to 0.5 percent by mass (in formula 1, R | 2014-04-24 |
20140113846 | DETERGENT FOR LUBRICANT OIL AND PRODUCTION PROCESS THEREOF - A lubricant oil detergent and a producing process thereof are disclosed. A process for producing a lubricant oil additive having a TBN from about 100 to about 400 includes reacting, at an elevated temperature, of composition (A) an alkyl salicylic acid or an alkyl salicylate ester, composition (B) an alkaline earth metal hydroxide added by one time or plural times during the reaction; composition (C) which contains at least one compound which is (i) an alcohol, or (ii) an carboxylic acid or an carboxylic anhydride; composition (D) base oil; and composition (E) carbon dioxide introduced after the composition (B) by one time, or introduced each time when the composition (B) is added if the composition (B) is added by plural times; solvent having a low boiling point is removed from the reacted mixture after the overbasing under vacuum, and the reacted mixture is filtered to obtain a clear liquid product. | 2014-04-24 |
20140113847 | HIGH VISCOSITY INDEX LUBRICATING OIL BASE STOCK AND VISCOSITY MODIFIER COMBINATIONS, AND LUBRICATING OILS DERIVED THEREFROM - A lubricating composition including a first base stock component including: one or more metallocene catalyzed polyalphaolefins (mPAOs), each mPAO having a kinematic viscosity (Kv | 2014-04-24 |
20140113848 | LUBRICATING OIL COMPOSITION - The present invention provides a lubricating oil composition for an internal combustion engine used mainly to drive a generator and to improve the fuel economy thereof. The composition comprises (A) a base oil being a hydrocarbon base oil having a ratio (CA/CB) of the proportion of the component of 24 or fewer carbon atoms (CA) and the proportion of the component of 25 or more carbon atoms (CB) in the carbon number distribution obtained by gas chromatography distillation of 2.0 or higher, the composition having a ratio (Vs/Vk) of the 80° C. high-temperature high-shear (HTHS) viscosity (Vk) and the 150° C. HTHS viscosity (Vs) of 0.35 or higher and a 100° C. kinematic viscosity of 2.5 mm | 2014-04-24 |
20140113849 | PHOTOLABILE PRO-FRAGRANCES - Fragrances having a fresh character are usually very volatile and therefore not very economical in typical applications such as washing or cleaning processes for example. For that reason they have to be used in relatively large amounts in order to bring about appropriate effects. The present invention describes photolabile pro-fragrances that allow for a greatly improved persistence of the fragrance impression, in particular one having a fresh character, in typical applications. A more economical use of the fragrances in question can be ensured in this way. | 2014-04-24 |
20140113850 | NOVEL USE OF HEPTYLPOLYGLYCOSIDES FOR SOLUBILISING NON-IONIC SURFACTANTS IN AQUEOUS ACIDIC CLEANING COMPOSITIONS, AND AQUEOUS ACIDIC CLEANING COMPOSITIONS COMPRISING SAME - A composition (C) of formula (I): R | 2014-04-24 |
20140113851 | COMPOSITIONS - The present application relates to cleaning and/or treatment compositions comprising anti-foams and methods of making and using such compositions. Such compositions encompass consumer products, cleaning and/or treatment compositions, fabric care compositions, or liquid laundry detergents that provide the desired suds profile via the addition of an antifoamer, yet are stable. | 2014-04-24 |
20140113852 | METHOD FOR PRODUCTION OF AN EMULSION - The present invention has as an objective to provide a new emulsification method, which can produce concentrated water-continuous emulsion containing lipophilic compounds in a dispersed phase, with a very fine dispersed phase droplet size less than a micron, and a narrow size distribution of the dispersed phase. This objective has been met by a method wherein a water-continuous emulsion is made using a Controlled Deformation Dynamic Mixer or a Cavity Transfer Mixer. | 2014-04-24 |
20140113853 | Transducible Polypeptides for Modifying Metabolism - Methods and compositions for modifying the metabolism of a subject are provided. One embodiment provides a recombinant polypeptide having a polynucleotide-binding domain, a protein transduction domain, and a targeting domain. In a preferred embodiment, the polynucleotide-binding domain includes one or more HMG box domains. | 2014-04-24 |
20140113854 | Locally-Active Anticoagulants and Anti-Inflammatory Agents - A locally-activatable bivalent thrombin binding agent is provided having two thrombin binding moieties for non-overlapping sites on a surface of thrombin linked together by a linker. The linker is a polypeptide having 5 to 30 amino acid residues existing in a folded state under an environmental condition where the binding agent is inactive. The linker changes conformation from the folded state to an unfolded state in response to a change in bulk temperature and/or to the presence of hyper-mobile water thereby activating the binding agent. Such locally-activatable thrombin binding agents can be administered systemically while only targeting specific sites of coagulation or inflammation since the thrombin binding agent will only activate at the site where the existence of atherosclerotic plaques has changed the local bulk temperature and/or created hyper-mobile water sufficiently to unfold the linker and activate the binding agent. Such binding agents are useful as site-specific anti-coagulant, anti-thrombotic and/or anti | 2014-04-24 |
20140113855 | Modified Release Formulations for Oprozomib - This disclosure features modified release pharmaceutical formulations (e.g., extended release pharmaceutical formulations; e.g., solid dosage forms, e.g., tablets) that are useful for the oral administration of oprozomib, or a pharmaceutically acceptable salt thereof, to a human or animal subject as well as methods of making and using the formulations. | 2014-04-24 |
20140113856 | Magnesium Compositions for Modulating the Pharmacokinetics and Pharmacodynamics of Insulin and Insulin Analogs, and Injection Site Pain - Compositions and methods for modulating injection site pain associated with rapid acting injectable insulin formulations have been developed for subcutaneous injection. The formulations contain insulin in combination with a zinc chelator such as ethylenediaminetetraacetic acid (“EDTA”), a dissolution/stabilization agent such as citric acid, a magnesium salt, and, optionally, additional excipients. New presentations include rapid acting concentrated insulin formulations and a way to enhance the absorption of commercially available rapid acting analog formulations by mixing them with a vial containing dry powder excipients that accelerate their absorption. Devices for mixing excipient and insulin together at the time of administration, while minimizing residence time of the mixture, are also described. | 2014-04-24 |
20140113857 | TARGETING DEREGULATED WNT SIGNALING IN CANCER USING STABILIZED ALPHA-HELICES OF BCL-9 - The invention provides structurally-constrained peptides by hydrocarbon stapling of a BCL9 HD2 helix for use as a therapeutic agent. The invention further provides methods and kits for use of the structurally-constrained peptide of the instant invention. The invention is based, at least in part, on the results provided herein demonstrating that hydrocarbon stapled helical peptides display excellent proteolytic, acid, and thermal stability, restore the native helical structure of the peptide, possess superior pharmacokinetic properties compared to the corresponding unmodified peptides, and are highly effective in binding to β-catenin in vitro, in cellulo, and in vivo, disrupting the BCL-9/β-catenin interaction, and thereby interfering with deregulated Wnt/β-catenin signaling for therapeutic benefit in a variety of human diseases including human cancer. | 2014-04-24 |
20140113858 | PEPTIDE FOR INHIBITION OF BINDING BETWEEN ANGIOPOIETIN-2 AND INTEGRIN AND USE THEREOF - There are provided an angiopoietin-2 (Ang2) derived peptides, polypeptides, and peptide complexes, and a method for inhibition of binding between Ang2 and integrin and prevention and/or treatment of a disease caused by the activation of Ang2 or the binding between Ang2 and integrin using the peptide, polypeptides, and peptide complexes. | 2014-04-24 |
20140113859 | USE OF LIVER GROWTH FACTOR (LGF) AS A NEURAL TISSUE REGENERATOR - A method of treating neurodegenerative diseases, such as Alzheimer's disease, with LGF administered systemically. | 2014-04-24 |
20140113860 | LONG-ACTING POLYPEPTIDES AND METHODS OF PRODUCING AND ADMINISTERING SAME - A polypeptide and polynucleotides comprising at least two carboxy-terminal peptides (CTP) of chorionic gonadotrophin attached to a non-human peptide-of-interest are disclosed. Pharmaceutical compositions comprising the non-human polypeptides and polynucleotides of the invention and methods of using both human and non-human polypeptides and polynucleotides are also disclosed. | 2014-04-24 |
20140113861 | CARTILAGE PRODUCT - The present invention relates to a method for preparing a cartilage product comprising a protein hydrolysate with a degree of hydrolysis comprised between 0.5% and 3.0%, at least one glycosaminoglycan and at least one growth factor. The present invention also relates to the cartilage product obtainable through said method. Said cartilage product is useful in the treatment or prevention of wounds, ulcers, burns, psoriasis, osteoarthritis, synovitis, osteoporosis, osteopenia, diseases of the tendons and ligaments, periodontal diseases, signs of skin aging, the harmful effects of ultraviolet radiation exposure or stretch marks. | 2014-04-24 |
20140113862 | METHOD FOR SITE-SPECIFIC POLYVALENT DISPLAY ON POLYMERS - The present invention relates to novel complex peptidomimetic products comprising multiple homogeneous or heterogeneous pendant groups that are site-specifically positioned along a linear oligomer or polymer scaffold and methods of making thereof. More specifically, the invention relates to N-substituted glycine peptoid oligomers or peptoids and their use as substrates for azide-alkyne [3+2]-cycloaddition conjugation reactions and subsequent additional rounds of oligomerization and cycloaddition. The methods of the invention may also be used to generate peptoid-peptide hybrid or peptide products comprising multiple homogeneous or heterogeneous pendant groups, which are positioned precisely along the linear oligomer or polymer scaffold. | 2014-04-24 |
20140113863 | METHODS COMPRISING DESMOPRESSIN - The present disclosure is directed to reducing nocturnal voids by administering a dose of desmopressin over a minimum treatment period compared to before administration, and maintaining or improving the reduction of nocturnal voids over the minimum treatment period. | 2014-04-24 |
20140113864 | Injectable Depot Composition - Gel compositions are provided that can be utilized as carriers for beneficial agents when injected into a subject and which can provide sustained release of the beneficial agent over time. In particular, gel compositions containing an agent that renders the composition thixotropic to facilitate injection of the gel into a subject with minimal discomfort to the subject are described. | 2014-04-24 |
20140113865 | USE OF PERTUSSIS TOXIN AS A THERAPEUTIC AGENT - The present application relates to the use of a pertussis toxin, and its derivatives, analogs, salts and pharmaceutical equivalents. In one embodiment, the invention provides a method of treating an autoimmune disease by administering pertussis toxin to the individual. In another embodiment, the autoimmune disease is multiple sclerosis. In another embodiment, the invention provides a method of treating a neurodegenerative disease such as Alzheimer's disease or Parkinson's disease by administering pertussis toxin, or a derivative, analog, salt or pharmaceutical equivalent. | 2014-04-24 |
20140113866 | NOVEL APPLICATION OF REDUCED-FAT SOYBEAN PROTEIN MATERIAL TO SOYBEAN-DERIVED RAW MATERIAL-CONTAINING FOOD OR BEVERAGE - The present invention addresses the problem of providing a soybean-derived raw material-containing food or beverage that improves problems with flavor and physical properties, such as the grassy smell caused by soybean raw materials, and markedly improves product quality, in a soybean-derived raw material-containing food or beverage using a conventional soybean raw material such soymilk or tofu. Provided are a milk-substitute composition, an egg yolk-substitute composition, and a composition for improving renal function, etc., characterized by including a reduced-fat soybean protein material having a total protein and carbohydrate content relative to dry material of at least 80 wt %, a fat content (as a chloroform/methanol mixed solvent extract) relative to the protein content of less than 10 wt %, and a total campesterol and stigmasterol (as plant-derived sterols) content of at least 200 mg relative to 100 g of fat. Also provided are a variety of soybean-derived raw material-containing food and beverages using these compositions. | 2014-04-24 |
20140113867 | APLS FOR TREATING ARTHRITIS - One embodiment of a therapeutic composition comprises one or more APLs, e.g., APL A12, for treating diseases or disorders related to arthritis, including rheumatoid arthritis. Another embodiment includes a method of inducing a Th2-type cytokine secretion profile in a mammal, including administering a therapeutic amount of A12 analog peptide. Another embodiment includes a method for generating functional T regulatory cells, the method including administering a therapeutic amount of APL A12 to a RA patient. | 2014-04-24 |
20140113868 | PEPTIDE ANALOGUES WITH AN EXCELLENT MOISTURIZING EFFECT AND USE THEREOF - The present invention relates to a peptide analogue or a pharmaceutically acceptable salt thereof with excellent moisturizing effect, and use thereof for moisturization. More specifically, the present invention relates to a novel peptide analogue or a pharmaceutically acceptable salt thereof, a method for preparation thereof, a moisturizing cosmetic composition comprising the same as an active ingredient, and a pharmaceutical composition for prevention and treatment of xeroderma. | 2014-04-24 |
20140113869 | Gbetagamma BINDING SITE ON THE PIK3CB GENE PRODUCT AND METHODS OF USE - Methods of treating a disease in a subject are provided comprising administering to the subject an amount of an agent which reduces, or prevents, interaction of a Gβγ with a pi 110β effective to treat the disease. Methods are also provided for identifying an inhibitor of interaction between a Gβγ and a ρ110β. Compositions are provided comprising a peptide comprising amino acid residues having the KAAEIASSDSANVSSRGGKKFLPV (SEQ ID NO:6). | 2014-04-24 |
20140113870 | METHOD OF TREATING PROSTATE CANCER WITH GnRH ANTAGONIST - The invention provides methods and dosing regimens for safely and effectively treating androgen-dependent prostate cancer with a gonadotrophin releasing hormone (GnRH) antagonist without causing a testosterone spike and/or other side effect of GnRH agonist therapy such as a urinary tract infection, or an arthralgia-related or cardiovascular side effect. | 2014-04-24 |
20140113871 | Modification of Peptides via SNAr Reactions of Thiols with Fluorinated Aromatics - Disclosed are compounds and methods relating to a chemical transformation for the conjugation of unprotected peptide biomolecules via a S | 2014-04-24 |
20140113872 | NOVEL AGONISTS AND ANTAGONISTS OF THE UROTENSINERGIC SYSTEM - Novel urotensin ll receptor (UT) agonists and antagonists are described herein. More specifically, novel derivatives of urotensin ll-related peptide (URP) are described herein. | 2014-04-24 |
20140113873 | CHITIN BINDING PROTEINS AND METHODS OF USE - Disclosed herein are methods of increasing epithelial cell proliferation (such as intestinal epithelial cell proliferation) by contacting epithelial cells with one or more CBPs. In some examples, the methods include administering the CBP to a subject, such as a subject in need of increased epithelial cell proliferation. Also disclosed herein are methods of identifying a subject having or at risk of developing hyperproliferation of epithelial cells (such as intestinal epithelial cells). Further disclosed are methods of decreasing epithelial cell proliferation by decreasing expression and/or activity of a CBP and methods of identifying inhibitors of epithelial cell proliferation and/or CBP activity. | 2014-04-24 |
20140113874 | Modified Compstatin With Improved Stability And Binding Properties - Compounds comprising peptides capable of binding C3 protein and inhibiting complement activation are disclosed. These cyclic compounds are modified to improve stability while maintaining substantially equivalent complement activation-inhibitory activity as compared with currently available compounds. The compounds comprise compstatin analogs in which the disulfide bond between C2 and C12 is modified via a thioether bond to form a cystathionine. | 2014-04-24 |
20140113875 | NOVEL SELF-ASSEMBLING DRUG AMPHIPHILES AND METHODS FOR SYNTHESIS AND USE - The present invention provides herein the design of monodisperse, amphiphilic anticancer drugs—which are now termed “drug amphiphiles” (DAs)—that can spontaneously associate into discrete, stable supramolecular nanostructures with the potential for self-delivery (no additional carriers are needed). The quantitative drug loading in the resulting nanostructures is ensured by the very nature of the molecular design. The DA is a composition comprising: D-L-PEP; wherein D is 1 to 4 hydrophobic drug molecules which can be the same or different; L is 1 to 4 biodegradable linkers which can be the same or different; and PEP is a peptide that can spontaneously associate into discrete, stable supramolecular nanostructures. In an alternate embodiment, the DA composition also comprises a targeting ligand (T). Methods of making DA molecules, as well as their use in treatment of disease are also provided. | 2014-04-24 |
20140113876 | BIOMARKERS FOR ASSESSING TREATMENT OF SIALIC ACID DEFICIENCY DISEASES AND CONDITIONS - The present invention relates to methods of monitoring and assessing sialic acid deficiency treatment as well as to methods of predicting/determining responsiveness to treatment for a sialic acid deficiency using biomarkers. Sialic acid deficiencies include for example Hereditary Inclusion Body Myopathy (HIBM). | 2014-04-24 |
20140113877 | NOVEL 3,4,4A,10B-TETRAHYDRO-1H-THIOPYRANO[4,3-C] ISOQUINOLINE COMPOUNDS - The compounds of formula (1) | 2014-04-24 |
20140113878 | COMPOSITIONS COMPRISING NORIBOGAINE AND AN EXCIPIENT TO FACILITATE TRANSPORT ACROSS THE BLOOD BRAIN BARRIER - This invention relates generally to compositions comprising noribogaine and an excipient to facilitate transport across the blood brain barrier. | 2014-04-24 |
20140113879 | BLOCK COPOLYMERS FOR STABLE MICELLES - The present invention relates to the field of polymer chemistry and more particularly to multiblock copolymers and micelles comprising the same. Compositions herein are useful for drug-delivery applications. | 2014-04-24 |
20140113880 | MODIFIED 2' AND 3'-NUCLEOSIDE PRODRUGS FOR TREATING FLAVIVIRIDAE INFECTIONS - 2′ and/or 3′ prodrugs of 1′, 2′, 3′ or 4′-branched nucleosides, and their pharmaceutically acceptable salts and derivatives are described. These prodrugs are useful in the prevention and treatment of Flaviviridae infections, including HCV infection, and other related conditions. Compounds and compositions of the prodrugs of the present invention are described. Methods and uses are also provided that include the administration of an effective amount of the prodrugs of the present invention, or their pharmaceutically acceptable salts or derivatives. These drugs may optionally be administered in combination or alteration with further anti-viral agents to prevent or treat Flaviviridae infections and other related conditions. | 2014-04-24 |
20140113881 | ANTIINFECTIVE COMPOSITION - The present invention relates to the use of hydroxymethyl-group-containing glycosaminoglycans, such as in particular hydroxymethyl-hyaluronic acid, for the treatment and prevention of infectious diseases or malignant or premalignant diseases, in particular of the skin or mucosa. The invention additionally provides a preparation method for glycosaminoglycans modified with hydroxymethyl groups. | 2014-04-24 |
20140113882 | Azaquinazoline Inhibitors of Atypical Protein Kinase C - The present application provides a compound of formula (I) | 2014-04-24 |
20140113883 | Therapeutic micro nutrient composition for lipolysis and sclerosis - An improved formulation and method for the removal of subcutaneous fat deposits in a human in need of such treatment. It also induces an inflammatory reaction which treats disorders of tissue adhesion which often accompany subcutaneous fat deposits or are created in the process of removal of subcutaneous fat deposits. This inflammatory reaction also limits the extent of the effect of the injected medication to a localized area. A lecithin and aqueous glucose and sodium chloride based biphasic injection dosage formulation is disclosed which is applicable to subcutaneous, intramuscular, and intravenous administration. Additionally, a program based approach to the treatment of subcutaneous fat deposits which includes injections of this formulation, application of compression garments, diet modification, and exercise is described. The formulation is characterized in that it comprises an adjustable acidifying agent to set pH, an antioxidant, a sclerosing agent, and a stabilizer. It is further characterized in that it includes liposomes, and that the components of these liposomes are therapeutic in the treatment of several human ailments. It is also efficacious in the treatment of striae albicantes, striae atrophicae, cellulite, and decreased skin turgor. | 2014-04-24 |
20140113884 | EPOXYEICOSATRIENOIC ACID ANALOGS AND METHODS OF MAKING AND USING THE SAME - Compounds and compositions comprising epoxyeicosatrienoic acid (EET) analogs that act as EET agonists and are useful as medications in the treatment of drug-induced nephrotoxicity, hypertension and other related conditions. Methods of making and using the compounds and compositions are further described. | 2014-04-24 |
20140113885 | ASSAYS AND METHODS OF TREATMENT RELATING TO VITAMIN D INSUFFICIENCY - Described herein are assays directed to determining the level of bioavailable or free vitamin D in a blood sample in a subject. The values determined for bioavailable or free vitamin D indicate whether the subject suffers from insufficient levels of vitamin D. Also described herein are methods of treatment for vitamin D insufficiency. | 2014-04-24 |
20140113886 | Stabilized 1, 25-Dihydroxyvitamin D2 and Method of Making Same - A stabilized 1,25-dihydroxyvitamin D | 2014-04-24 |